Suspension of trading
PharmaSGP Holding SE Stock Deutsche Boerse AG
Stocks
PSG
DE000A2P4LJ5
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.80 EUR | +0.70% |
|
-.--% | - |
| 25-09-23 | PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 25-09-11 | PharmaSGP Holding SE Reaffirms Earnings Guidance for the Financial Year 2025 | CI |
| 1 day | +0.70% |
| 1 year | 28 |  | 29.6 |
| 3 years | 18 | | 29.6 |
| 5 years | 18 | | 29.6 |
| 10 years | 14.8 | | 37.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 2024-12-31 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 2020-03-03 |
| Director/Board Member | 45 | 2020-03-03 | |
Axel Rebien
BRD | Director/Board Member | 54 | 2020-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.70% | -.--% | - | - | 447M | |
| -1.21% | -3.04% | +44.03% | +142.51% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.36% | 550B | |
| -2.14% | -4.94% | +16.83% | +58.18% | 382B | |
| -0.36% | -3.09% | +23.33% | +16.78% | 316B | |
| -0.01% | +0.18% | +26.91% | +14.00% | 272B | |
| -0.10% | -1.75% | +24.23% | +31.16% | 268B | |
| -1.08% | +1.68% | -35.56% | -46.52% | 199B | |
| -1.19% | -4.95% | +16.68% | +48.70% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.46% | 154B | |
| Average | -0.40% | -2.70% | +20.33% | +40.40% | 366.93B | |
| Weighted average by Cap. | -0.54% | -3.50% | +29.59% | +63.50% |
Employees
98
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PSG Stock
- PSG Stock
Select your edition
All financial news and data tailored to specific country editions
